Search

The US patent office has released studies on international patenting and prior user defence, with other reports looking at the US patents scene to follow

Hard-pressed healthcare systems can no longer pay premium prices for new drugs. The consequence will be less innovation in Europe says Andrew Witty, CEO of GlaxoSmithKline.

In total, 8,900 small companies have won grants worth €2.4B

25 countries have agreed to back a single European research plan in neurodegenerative diseases. This is a defining moment for coordinated research says the Commissioner

The European Commission proposes to unite national funding agencies in ‘pacts’ to complete the European Research Area (ERA) by 2014 deadline - without further legislation

Only world-class science will deliver the innovation and growth Europe so desperately needs. US experience can help EU policy makers understand how to enhance R&D productivity and encourage excellence, says Paula Stephan

The $1,000 genome has arrived, providing the spur for personalised healthcare to move from theory to practice. Some existing examples of best practice and roadmaps for the future are pointing the way

Personalised healthcare promises long-term value. But how can Europe justify the upfront costs at a time of massive cuts in public spending?